JP2007517885A - 眼に投与するためのメマンチンおよびポリアニオン性ポリマーを含む組成物 - Google Patents

眼に投与するためのメマンチンおよびポリアニオン性ポリマーを含む組成物 Download PDF

Info

Publication number
JP2007517885A
JP2007517885A JP2006549374A JP2006549374A JP2007517885A JP 2007517885 A JP2007517885 A JP 2007517885A JP 2006549374 A JP2006549374 A JP 2006549374A JP 2006549374 A JP2006549374 A JP 2006549374A JP 2007517885 A JP2007517885 A JP 2007517885A
Authority
JP
Japan
Prior art keywords
component
composition
eye
adamantane
neuroprotective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006549374A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007517885A5 (cg-RX-API-DMAC10.html
Inventor
パトリック・エム・ヒューズ
オレスト・オレジュニック
レット・シフマン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/752,125 external-priority patent/US20050147584A1/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of JP2007517885A publication Critical patent/JP2007517885A/ja
Publication of JP2007517885A5 publication Critical patent/JP2007517885A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2006549374A 2004-01-05 2005-01-04 眼に投与するためのメマンチンおよびポリアニオン性ポリマーを含む組成物 Withdrawn JP2007517885A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/752,125 US20050147584A1 (en) 2004-01-05 2004-01-05 Compositions and methods comprising memantine and polyanionic polymers
US10/941,272 US20050031652A1 (en) 2003-02-25 2004-09-14 Compositions and methods comprising memantine and polyanionic polymers
PCT/US2005/000249 WO2005067891A1 (en) 2004-01-05 2005-01-04 Compositions comprosing memantine and polyanionic polymers for administration to the eye

Publications (2)

Publication Number Publication Date
JP2007517885A true JP2007517885A (ja) 2007-07-05
JP2007517885A5 JP2007517885A5 (cg-RX-API-DMAC10.html) 2008-02-21

Family

ID=34798997

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006549374A Withdrawn JP2007517885A (ja) 2004-01-05 2005-01-04 眼に投与するためのメマンチンおよびポリアニオン性ポリマーを含む組成物

Country Status (7)

Country Link
US (1) US20050031652A1 (cg-RX-API-DMAC10.html)
EP (1) EP1701700A1 (cg-RX-API-DMAC10.html)
JP (1) JP2007517885A (cg-RX-API-DMAC10.html)
AU (1) AU2005204365A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0506689A (cg-RX-API-DMAC10.html)
CA (1) CA2552521A1 (cg-RX-API-DMAC10.html)
WO (1) WO2005067891A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009884A1 (en) * 1997-06-30 2005-01-13 Dreyer Evan B. Calcium blockers to treat proliferative retinal diseases
JP2002182418A (ja) * 2000-12-11 2002-06-26 Konica Corp 画像形成方法、画像形成装置
US20080033053A1 (en) * 2004-07-22 2008-02-07 Wolfgang Curt D Cross-Reference To Related Applications
JP2008507588A (ja) * 2004-07-26 2008-03-13 アラーガン、インコーポレイテッド 眼の病態を処置する方法
US20070167527A1 (en) * 2006-01-13 2007-07-19 Burke James A Memantine for the normalization of visual acuity deficits
SI2074123T1 (sl) 2006-10-16 2013-03-29 Bionomics Limited Nove anksiolitične spojine
US10954231B2 (en) 2006-10-16 2021-03-23 Bionomics Limited Anxiolytic compounds
WO2008098027A2 (en) * 2007-02-06 2008-08-14 Allergan, Inc. Treatment of ischemic retinal conditions with memantine
WO2011071995A2 (en) 2009-12-08 2011-06-16 Case Western Reserve University Compounds and methods of treating ocular disorders
WO2012116415A1 (en) 2011-03-02 2012-09-07 Bionomics Limited Novel small-molecules as therapeutics
CN103649086A (zh) 2011-05-12 2014-03-19 生态学有限公司 制备萘啶的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554367A (en) * 1984-10-31 1996-09-10 Alcon Laboratories, Inc. Compositions for treatment of glaucoma
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
US4738851A (en) * 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
US5008242A (en) * 1986-12-24 1991-04-16 John Lezdey Treatment of inflammation using 1-antichymotrypsin
US5221696A (en) * 1989-03-29 1993-06-22 Alcon Laboratories, Inc. Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
US5691316A (en) * 1994-06-01 1997-11-25 Hybridon, Inc. Cyclodextrin cellular delivery system for oligonucleotides
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US6380261B1 (en) * 1997-06-30 2002-04-30 Allergan Sales, Inc. Calcium blockers to treat proliferative vitreoretinopathy
AU761824B2 (en) * 1998-10-27 2003-06-12 Alcon Laboratories, Inc. Treatment of disorders of the outer retina
US6258350B1 (en) * 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
CA2368242A1 (en) * 1999-03-12 2000-09-21 Alcon Laboratories, Inc. Combination therapy for treating glaucoma
US6482854B1 (en) * 1999-03-25 2002-11-19 Massachusetts Eye And Ear Infirmary Glaucoma treatment
SK282717B6 (sk) * 2000-03-10 2002-11-06 �Stav Experiment�Lnej Farmakol�Gie Sav Spôsob prípravy ultravysokomolekulových hyalurónanov
US6572849B2 (en) * 2000-09-20 2003-06-03 Lee Shahinian, Jr. Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications
US6761694B2 (en) * 2001-12-13 2004-07-13 Allergan, Inc. Methods for measuring retinal damage
US6982079B2 (en) * 2002-04-26 2006-01-03 Allergan, Inc. Compositions for treating hyperemia
EP1654002B2 (en) * 2003-08-07 2014-01-29 Allergan, Inc. Compositions for delivery of therapeutics into the eyes

Also Published As

Publication number Publication date
WO2005067891A1 (en) 2005-07-28
US20050031652A1 (en) 2005-02-10
BRPI0506689A (pt) 2007-05-02
CA2552521A1 (en) 2005-07-28
EP1701700A1 (en) 2006-09-20
AU2005204365A1 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
Fraunfelder et al. Ocular toxicity of antineoplastic agents
EP2262476B1 (en) Drug delivery to the anterior and posterior segments of the eye using eye drops.
WO2010125416A1 (en) Drug delivery to the anterior and posterior segments of the eye
RS63136B9 (sr) Lekoviti sastav koji sadrži tivozanib
CN109996814B (zh) 多激酶抑制剂及在眼部纤维化中的用途
WO1989010757A1 (en) New ophthalmic preparation for treating glaucoma
US5212168A (en) Method of and solution for treating glaucoma
JP2005533087A (ja) 神経損傷の処置にリアノジン拮抗剤を用いる方法
US20050031652A1 (en) Compositions and methods comprising memantine and polyanionic polymers
CN103977011B (zh) 含有曲伏前列素和噻吗洛尔的眼用凝胶剂及其制备方法
JP2009519962A (ja) 眼投与用局所メカミルアミン製剤およびその使用
JP2967523B2 (ja) 眼病用製薬組成物
WO2019024433A1 (zh) 氨基金刚烷胺单硝酸酯类化合物眼用组合物及其制剂和应用
JP4838968B2 (ja) 薬物−ポリエチレングリコール結合体を含有する眼組織内注入剤
WO2002040028A1 (fr) Gouttes pour les yeux en gel antibacterien
CA2453442A1 (en) Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases
EP4087533B1 (en) Soluble melatonin tripartate adduct for the prevention and treatment of rare and severe eye sight-threatening conditions and neuro-ophthalmic disorders
JP7114668B2 (ja) エピナスチン又はその塩を含有する花粉破裂抑制剤
US20050277698A1 (en) Memantine delivery to the back of the eye
US20050147584A1 (en) Compositions and methods comprising memantine and polyanionic polymers
JPS63502270A (ja) 散瞳作用を有する眼科用医薬組成物
JPH04247036A (ja) 縮瞳をおこすことなく眼圧を下げる治療方法
CN1633308A (zh) 使用脲和脲衍生物治疗眼病
EP4661868A1 (en) Alpha-2-adrenergic agonists for improving vision
JP2002356431A (ja) ステロイドを有効成分とする網脈絡膜疾患治療剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071227

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071227

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20090122